Clinical Trials Logo

Hemoglobinuria clinical trials

View clinical trials related to Hemoglobinuria.

Filter by:
  • Approved for marketing  
  • Page 1

NCT ID: NCT00438789 Approved for marketing - Clinical trials for Hemoglobinuria, Paroxysmal

The Paroxysmal Nocturnal Hemoglobinuria Early Access Treatment Protocol

EMBRACE
Start date: n/a
Phase: Phase 3
Study type: Expanded Access

The primary objective is to provide access to eculizumab for PNH patient pending commercial availability.